Top

Published in:

25-01-2023 | ST-Segment Elevation Myocardial Infarction | Original Article

Feasibility of concomitant left atrial appendage closure and percutaneous coronary intervention in patients with acute coronary syndrome and atrial fibrillation: a randomized pilot study

Published in: Heart and Vessels | Issue 7/2023

Abstract

The optimal approach for prevention of cardiovascular events and reduction of bleeding in patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) is still controversial. The aim of our study is to asses our single-center experience with concomitant left atrial appendage occlusion (LAAO) and percutaneous coronary intervention (PCI). 50 patients with ACS without ST elevation and history of AF were randomized after successful PCI to LAAO or conventional medical therapy. The primary endpoints were safety and length of hospitalization. The follow-up period was 30 days. The mean procedural times were 113 ± 23 min PCI + LAAO implantation and 39 ± 19 min of PCI only (p < 0.001), while mean fluoroscopy times were 18 ± 8 min and 12 ± 8 min (p < 0.001), respectively. No procedure-related complications were observed. There was no difference observed for length of hospitalization between two groups. LAAO in patients with ACS and AF undergoing PCI appears safe.

Graphical abstract

Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen JK, Cuisset T, Kirchhof P, Marín F, Document of European Society of Cardiology Working Group on Thrombosis (2010) Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a consensus document of the European society of cardiology working group on thrombosis, endorsed by the European heart rhythm association (EHRA) and the European association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J 31:1311–1318CrossRefPubMed

Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM, ESC Scientific Document Group (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289–1367CrossRefPubMed

Ruiz-Nodar JM, Marın F, Roldan V, Valencia J, Manzano-Fernandez S, Caballero L, Hurtado JA, Sogorb F, Valdes M, Lip GY (2012) Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv 5:459–466CrossRefPubMed

Rubboli A, Faxon D, Airaksinen K, Schlitt A, Marin F, Bhatt D, Lip G (2014) The optimal management of patients on oral anticoagulation undergoing coronary artery stenting the 10th anniversary overview. Thromb Haemost 112:1080–1087CrossRefPubMed

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H, Heidbuchel H, Hendriks J, Hindricks G, Manolis A, Oldgren J, Popescu B, Schotten U, Putte B, Vardas P (2016) ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRefPubMed

Holmes D, Kar S, Price M, Whisenant B, Sievert H, Doshi S, Huber K, Reddy V (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy the PREVAIL trial. J Am Coll Cardiol 64:1–12CrossRefPubMed

Holmes DR, Reddy VY, Turi ZG, Doshi S, Sievert H, Buchbinder M, Mullin C, Sick P (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised noninferiority trial. Lancet 374:534–542CrossRefPubMed

Romanov A, Pokushalov E, Artemenko S, Yakubov A, Stenin I, Kretov E, Krestianinov O, Grazhdankin I, Risteski D, Karaskov A, Steinberg J (2015) Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial. J Interv Card Electrophysiol 44:9–16CrossRefPubMed

Phillips KP, Pokushalov E, Romanov A, Artemenko S, Folkeringa R, Szili-Torok T, Senatore G, Stein K, Razali O, Gordon N, Boersma L (2018) Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up. Europace 20:949–955CrossRefPubMed

10.

Chue CD, de Giovanni J, Steeds RP (2011) The role of echocardiography in percutaneous left atrial appendage occlusion. Eur J Echocardiogr 12:i3–i10CrossRefPubMed

11.

Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, Fauchier L, Betts TR, Lewalter T, Saw J, Tzikas A, Sternik L, Nietlispach F, Berti S, Sievert H, Bertog S, Meier B (2020) EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EuroIntervention 15(13):1133–1180CrossRefPubMed

12.

Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123(23):2736–2747CrossRefPubMed

13.

Cannon CP, Bhatt DL, Oldgren J, Lip GY, Ellis S, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi J, Berg J, Steg P, Hohnloser S (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377:1513–1524CrossRefPubMed

14.

Bonaca MP, Storey RF, Theroux P, Steg PG, Bhatt DL, Cohen MC, Im K, Murphy SA, Magnani G, Ophuis TO, Rudah M, Parkhomenko A, Isaza D, Kamensky G, Goudev A, Montalescot G, Jensen EC, Johanson P, Braunwald E, Sabatine MS (2017) Efficacy and safety of ticagrelor over time in patients with prior MI in PEGASUS-TIMI 54. J Am Coll Cardiol 70(11):1368–1375CrossRefPubMed

15.

Jones DW, Minhas S, Fierro JJ, Ardeshna D, Rawal A, Cave B, Shah SP, Khouzman B (2019) From WOEST to AUGUSTUS: a review of safety and efficacy of triple versus dual antithrombotic regimens in patients with atrial fibrillation requiring percutaneous coronary intervention for acute coronary syndrome. Ann Transl Med 7:405CrossRefPubMedPubMedCentral

16.

Kalbacher D, Waldeyer C, Blankenberg S, Westermann D (2018) Beyond conventional secondary prevention in coronary artery disease-what to choose in the era of CANTOS, COMPASS, FOURIER, ODYSSEY and PEGASUS-TIMI 54? A review on contemporary literature. Ann Transl Med 6(16):323CrossRefPubMedPubMedCentral

17.

Lopes RD, Heizer G, Aronson R, Vora A, Massaro T, Mehran R, Goodman S, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey R, Thiele H, Vinereanu D, Granger C, Alexander JH (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 380:1509–1524CrossRefPubMed

18.

Alhejily WA, Ohman EM (2012) Repeat revascularization after PCI: are we reinventing the wheel or refining Achilles’ heel? Circ Cardiovasc Interv 5(6):746–747CrossRefPubMed

19.

Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, Pigrim T, Hong M, Kim HS, Colombo A, Steg P, Zanchin T, Palmerini T, Wallentin L, Bhatt D, Stone G, Windecker S, Steyerberg E, Valgimigli M (2017) Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389:1025–1034CrossRefPubMed

20.

Alexander JH, Lopes RD, James S, Kilaru L, He Y, Mohan P, Bhatt D, Goodman S, Verheugt F, Flather M, Huder K, Liaw D, Husted S, Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel J, Cools F, Atar D, Leiva-Pons J, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington R, Wallentin L (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708CrossRefPubMed

21.

Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson M, Kovar F, Kala P, Garcia-Hernandez A, Renfurm R, Granger C (2011) RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. Eur Heart J 32:2541–2554CrossRefPubMedPubMedCentral

Title: Feasibility of concomitant left atrial appendage closure and percutaneous coronary intervention in patients with acute coronary syndrome and atrial fibrillation: a randomized pilot study
Publication date: 25-01-2023
Keywords: ST-Segment Elevation Myocardial Infarction
Acute Coronary Syndrome
Atrial Fibrillation
Published in: Heart and Vessels / Issue 7/2023
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-023-02236-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Feasibility of concomitant left atrial appendage closure and percutaneous coronary intervention in patients with acute coronary syndrome and atrial fibrillation: a randomized pilot study

Abstract

Graphical abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Graphical abstract

Please log in to get access to this content

Other articles of this Issue 7/2023

Rescue aortic valvuloplasty for severe aortic stenosis is simple and effective in severely hemodynamically compromised patients presenting to centers without on-site heart surgery or TAVI facilities

Zinc supplementation in patients with acute myocardial infarction

Relation between laxative use and risk of major bleeding in patients with atrial fibrillation and heart failure

Clinical implication of device-based algorithm that optimize atrioventricular delay during cardiac resynchronization therapy: author’s reply

Relationship between coronary artery calcium score and bleeding events after percutaneous coronary intervention in chronic coronary syndrome

First clinical experience using a novel automated mapping algorithm for mapping of ventricular arrhythmias

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page